MyMyelomaTeam

The knowledge base does not mention a specific regimen combining VRD (Velcade, Revlimid, and Dexamethasone) with Isatuximab. However, Isatuximab has been combined with other treatments for relapsed or refractory multiple myeloma, such as:

- Isatuximab-irfc (Sarclisa) with pomalidomide and dexamethasone for those who had Show Full Answer

The knowledge base does not mention a specific regimen combining VRD (Velcade, Revlimid, and Dexamethasone) with Isatuximab. However, Isatuximab has been combined with other treatments for relapsed or refractory multiple myeloma, such as:

- Isatuximab-irfc (Sarclisa) with pomalidomide and dexamethasone for those who had prior treatment with two or more other medications.
- Isatuximab-irfc with dexamethasone and carfilzomib (Kyprolis) for those who have tried between one and three previous treatments.

These combinations have shown effectiveness in treating relapsed or refractory multiple myeloma. For specific results and experiences, consulting a healthcare provider or clinical trial data would be necessary.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Treatment Options for Relapsed or Refractory Myeloma | MyMyelomaTeam

Refractory Myeloma: 6 Treatment Options | MyMyelomaTeam